January 23
download app
download appDOWNLOAD OUR APP
download google-play
download app-store
Dolores Utrilla
23rd March 2021
Consumer, Health & Environment Covid-19 Institutional law

European Ombudsman finds no maladministration in Commission’s transparency mechanisms regarding purchase of COVID-19 vaccines, but suggests certain improvements

The European Ombudsman has delivered a decision (in case 175/2021/DL) finding no maladministration in the way in which the European Commission ensures transparency in relation to the team responsible for negotiating ‘advanced purchase agreements’ (APAs) with pharmaceutical companies for vaccines against COVID-19.

The complainant, a Member of the European Parliament, had submitted a request to the European Commission for public access concerning (1) the APA negotiated and signed with AstraZeneca, and (2) the names of the persons negotiating on behalf of the EU Member States. In late January 2021, the Commission made public a redacted version of the APA with AstraZeneca. The Ombudsman welcomed these developments and consequently ope


Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.